Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.
Consumption of L-arginine contributes to reduced bioavailability of nitric oxide (NO) that is critical for the development of ischemia-reperfusion injury. The aim of the study was to determine myocardial arginase expression and activity in ischemic-reperfusion myocardium and whether local inhibition...
Main Authors: | Adrian T Gonon, Christian Jung, Abram Katz, Håkan Westerblad, Alexey Shemyakin, Per-Ove Sjöquist, Jon O Lundberg, John Pernow |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3409239?pdf=render |
Similar Items
-
Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.
by: Oskar Kövamees, et al.
Published: (2014-01-01) -
The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo.
by: Attila Kiss, et al.
Published: (2014-01-01) -
ENDOTHELIOPROTECTIVE AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR
by: V. I. Yakushev, et al.
Published: (2015-06-01) -
Long-term cardioprotection with phosphodiesterase-5 inhibition against ischemia-reperfusion injury: Role of nitric oxide.
by: Daoud, Vladimir Paul
Published: (2005) -
Nitric Oxide and Postconditioning: Cardioprotective Methods for Acute Care of Ischemia Reperfusion Injury
by: Pong, Terrence Kwok Cay
Published: (2012)